D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.23% |
| 2 | Consumer Discretionary | 11.75% |
| 3 | Healthcare | 9.92% |
| 4 | Financials | 7.86% |
| 5 | Industrials | 6.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
Genuine Parts
GPC
$17.2B
| $3.91M | ﹤0.01% |
36,794
-81,707
| -69% | -$8.4M |
|
1877
Flowserve
FLS
$9.63B
| $3.91M | ﹤0.01% |
78,531
+38,513
| +96% | +$1.84M |
|
1878
Campbell Soup
CPB
$6.58B
| $3.9M | ﹤0.01% |
78,897
+9,138
| +13% | +$433K |
|
1879
CALL
Verisk Analytics
VRSK
$26.1B
| $3.9M | ﹤0.01% |
26,100
| – | – |
|
1880
AtriCure
ATRC
$2.04B
| $3.89M | ﹤0.01% |
119,769
+18,294
| +18% | +$521K |
|
1881
PUT
Novartis
NVS
$301B
| $3.89M | ﹤0.01% |
+41,100
| New | +$3.69M |
|
|
MRTX
1882
CALL
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $3.89M | ﹤0.01% |
30,200
+20,000
| +196% | +$1.93M |
|
|
KSU
1883
CALL
DELISTED
Kansas City Southern
KSU
| $3.89M | ﹤0.01% |
+25,400
| New | +$3.73M |
|
1884
PUT
United Therapeutics
UTHR
$26.2B
| $3.88M | ﹤0.01% |
44,100
-9,200
| -17% | -$810K |
|
1885
W.R. Berkley
WRB
$27.2B
| $3.88M | ﹤0.01% |
+126,338
| New | +$3.9M |
|
|
VNET
1886
VNET Group
VNET
$2.08B
| $3.88M | ﹤0.01% |
534,492
+15,338
| +3% | +$116K |
|
1887
CALL
Rockwell Automation
ROK
$52.4B
| $3.87M | ﹤0.01% |
19,100
+14,100
| +282% | +$2.61M |
|
1888
CALL
NIO
NIO
$12.1B
| $3.86M | ﹤0.01% |
961,100
+875,900
| +1,028% | +$1.76M |
|
1889
PUT
Alexandria Real Estate Equities
ARE
$9.15B
| $3.86M | ﹤0.01% |
23,900
+600
| +3% | +$94.6K |
|
1890
Genesco
GCO
$429M
| $3.86M | ﹤0.01% |
80,595
-65,480
| -45% | -$2.72M |
|
1891
First Citizens BancShares
FCNCA
$24.6B
| $3.86M | ﹤0.01% |
7,255
-3,884
| -35% | -$1.97M |
|
1892
CALL
Equity Lifestyle Properties
ELS
$12.7B
| $3.86M | ﹤0.01% |
54,800
+12,800
| +30% | +$890K |
|
1893
CALL
Williams-Sonoma
WSM
$27.5B
| $3.85M | ﹤0.01% |
+104,800
| New | +$3.64M |
|
1894
CALL
Zscaler
ZS
$24B
| $3.85M | ﹤0.01% |
82,700
-33,500
| -29% | -$1.55M |
|
1895
Ribbon Communications
RBBN
$373M
| $3.84M | ﹤0.01% |
1,239,041
+205,740
| +20% | +$819K |
|
1896
Vishay Intertechnology
VSH
$5.18B
| $3.84M | ﹤0.01% |
180,300
-185,192
| -51% | -$3.59M |
|
|
SIX
1897
PUT
DELISTED
Six Flags Entertainment Corp.
SIX
| $3.83M | ﹤0.01% |
+84,900
| New | +$3.91M |
|
1898
Independent Bank Corp
IBCP
$787M
| $3.83M | ﹤0.01% |
168,970
+6,110
| +4% | +$135K |
|
|
UFS
1899
PUT
DELISTED
DOMTAR CORPORATION (New)
UFS
| $3.82M | ﹤0.01% |
100,000
| – | – |
|
1900
PUT
Agios Pharmaceuticals
AGIO
$1.95B
| $3.82M | ﹤0.01% |
80,000
+10,000
| +14% | +$378K |
|
Similar funds
D.E. Shaw & Co's Q4 2019 Portfolio in Review
As of Q4 2019, D.E. Shaw & Co held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
D.E. Shaw & Co's Q4 2019 filing shows 572 new, 1,477 increased, 1,498 reduced and 412 closed positions. Its largest new stake was Tesla: 17,953,230 shares worth $501M. The largest sale was Alibaba, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- D.E. Shaw & Co added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- D.E. Shaw & Co's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- D.E. Shaw & Co fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- D.E. Shaw & Co's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- D.E. Shaw & Co opened 572 new positions and closed 412 in Q4 2019.
- D.E. Shaw & Co's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.